Skip to main content
. 2019 May 20;13(2):172–178. doi: 10.1093/ckj/sfz056

Table 1.

Baseline characteristics of the study population (N = 78)

General characteristics
 Sex (male), % 66
 Age (years) 62 ± 16
 Charlson index 7.2 ± 2.7
 Diabetes, % 30
 Hypertension, % 90
 Dyslipidaemia, % 60
CKD aetiology, %
 Glomerular 40
 Diabetes 24
 Vascular 17
 Interstitial 9
 Polycystic kidney disease 5
 Others 5
Dialysis features
 Dialysis vintage (months) 27 (9–52)
Kt/Vurea 2.0 ± 0.4
 Serum B2M (mg/dL) 25.1 ± 7.5
 B2M reduction ratio, % 79.2 ± 14.1
 OL-HDF, % 82 ± 23
 Convective volume (L) 28.7 ± 6.5
 Convective volume adjusted to ECW 1.7 ± 0.5
 AV fistula, % 66 ± 12
Laboratory parameters
 YKL-40 (ng/mL) 207 ± 106
 Haemoglobin (g/L) 11.4 ± 1.1
 TSI (%) 29.4 ± 10.1
 Albumin (g/dL) 3.7 ± 0.3
 Prealbumin (mg/dL) 23.5 ± 6.2
 CRP (mg/dL) 0.4 (0.1–1.1)
 Total cholesterol (mg/dL) 142.5 ± 37.5
 Triglycerides (mg/dL) 120.0 ± 64.2
 HbA1c (%) 5.7 ± 1.0
 BNP (pg/mL) 188 (90–408)
 NT-proBNP (ng/dL) 3450 (1350–8410)
 Troponin T (ng/mL) 53.1 (31.7–76.2)
 Calcium (mg/dL) 8.5 ± 0.6
 Phosphorus (mg/dL) 4.1 ± 1.3
 PTH (pg/mL) 420 (177–631)
 Vitamin D (µg/L) 10.3 ± 4.4
Hydration status and body composition
 BMI (kg/m²) 25.9 ± 4.9
 LTI (kg/m²) 15.6 ± 4.0
 FTI (kg/m²) 12.0 ± 9.3
 OH (L) 1.3 (−0.02–2.2)
 ECW (L) 17.0 ± 3.5
 ICW (L) 19.7 ± 4.7
 ECW/ICW 0.8 ± 0.1
 OH/ECW (%) 2.3 ± 0.8
Medications
 Patients with antihypertensive treatment, % 50
 Number of antihypertensive 1.5 (0–3)
 Patients with erythropoietin treatment, % 89
 Doses erythropoietin per week (IU/week) 4067 ± 1043
Echocardiographic data
 LVEF (%) 50 ± 10
 LVMI (g/m2) 132 ± 45

Variables with this symbol were expressed as median IQR or mean ± SD.

OL HDF, Online hemodiafiltration; TSI, transferrin saturation index; BNP, brain natriuretic protein; BMI, body mass index; LTI, lean tissue index; FTI, fat tissue index; OH, overhydration; ECW, extracellular water; ICW, intracellular water; LVEF, left ventricular ejection fraction; LVMI, left ventricular mass index.